FXYD proteins: new regulators of Na-K-ATPase

American Journal of Physiology - Renal Physiology - Tập 290 Số 2 - Trang F241-F250 - 2006
Käthi Geering1
1Dept. of Pharmacology and Toxicology, Univ. of Lausanne, Rue du Bugnon 27, 1005 Lausanne, Switzerland. [email protected]

Tóm tắt

FXYD proteins belong to a family of small-membrane proteins. Recent experimental evidence suggests that at least five of the seven members of this family, FXYD1 (phospholemman), FXYD2 (γ-subunit of Na-K-ATPase), FXYD3 (Mat-8), FXYD4 (CHIF), and FXYD7, are auxiliary subunits of Na-K-ATPase and regulate Na-K-ATPase activity in a tissue- and isoform-specific way. These results highlight the complexity of the regulation of Na+and K+handling by Na-K-ATPase, which is necessary to ensure appropriate tissue functions such as renal Na+reabsorption, muscle contractility, and neuronal excitability. Moreover, a mutation in FXYD2 has been linked to cases of human hypomagnesemia, indicating that perturbations in the regulation of Na-K-ATPase by FXYD proteins may be critically involved in pathophysiological states. A better understanding of this novel regulatory mechanism of Na-K-ATPase should help in learning more about its role in pathophysiological states. This review summarizes the present knowledge of the role of FXYD proteins in the modulation of Na-K-ATPase as well as of other proteins, their regulation, and their structure-function relationship.

Từ khóa


Tài liệu tham khảo

10.1152/ajprenal.00376.2001

10.1074/jbc.M111552200

10.1074/jbc.274.47.33183

10.1152/ajprenal.00146.2001

10.1073/pnas.92.13.6092

10.1093/emboj/20.15.3993

10.1093/emboj/cdf330

10.1093/emboj/16.14.4250

10.1152/ajprenal.1998.275.5.F633

10.1016/S0378-1119(01)00497-8

10.1210/endo.140.3.6582

10.1073/pnas.231309198

10.1152/ajprenal.00026.2004

10.1073/pnas.1130871100

10.1385/NMM:6:2-3:105

10.1152/ajpcell.1996.271.3.C753

10.1161/01.RES.82.3.367

Cornelius Fand Mahmmoud YA.Functional modulation of the sodium pump: the regulatory proteins “Fixit.”News Physiol Sci18: 119–124, 2003.

10.1073/pnas.182267299

Crambert Gand Geering K.FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase.Sci STKE166: RE1, 2003.

10.1074/jbc.275.3.1976

10.1091/mbc.E04-10-0878

10.1074/jbc.M313494200

10.1016/S1570-9639(02)00473-9

10.1016/j.neuron.2004.06.028

10.1038/ng1081

10.1074/jbc.M009131200

10.1074/jbc.M410737200

10.1046/j.1432-0436.2001.680205.x

10.1152/physrev.2001.81.1.345

10.1074/jbc.M402187200

10.1523/JNEUROSCI.23-06-02161.2003

10.1021/bi00610a037

10.1128/MCB.17.3.1503

Fuller W, Eaton P, Bell JR, and Shattock MJ.Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K ATPase.FASEB J18: 197–199, 2003.

10.1074/jbc.M500080200

10.1152/ajprenal.00112.2002

10.1023/A:1010623724749

10.1046/j.1523-1755.2001.0590051812.x

10.1159/000076932

Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, and Burfeind P.Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.Int J Oncol24: 97–105, 2004.

10.1006/jmbi.2001.5137

10.1152/physiol.00013.2004

10.1073/pnas.012425299

10.1152/ajpheart.00142.2004

10.1074/jbc.M500697200

10.1016/j.molbrainres.2004.03.021

10.1096/fj.03-0773fje

10.1074/jbc.M001411200

Laski MEand Kurtzman NA.The renal adenosine triphosphatases—functional integration and clinical significance.Miner Electrolyte Metab22: 410–422, 1996.

10.1074/jbc.M406697200

10.1074/jbc.M213253200

Lu KP, Kemp BE, and Means AR.Identification of substrate specificity determinants for the cell cycle-regulated NIMA protein kinase.J Biol Chem269: 6603–6607, 1994.

10.1016/S0006-3495(02)75540-9

10.1074/jbc.M305126200

10.1074/jbc.M005168200

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, and Johnston PG.Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.Cancer Res63: 4602–4606, 2003.

10.1038/81543

10.1083/jcb.121.3.579

10.1152/ajpheart.00997.2003

10.1038/nature01335

10.1038/377737a0

Moorman JR, Palmer CJ, John JE III, Durieux ME, and Jones LR.Phospholemman expression induces a hyperpolarization-activated chloride current inXenopusoocytes.J Biol Chem267: 14551–14554, 1992.

10.1016/S0167-4889(00)00023-9

10.1016/S0167-4889(01)00082-9

Morrison BWand Leder P.Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.Oncogene9: 3417–3426, 1994.

10.1074/jbc.270.5.2176

10.1074/jbc.M000899200

10.1016/S0167-4889(99)00102-0

10.1016/S0167-4781(00)00251-7

Palmer CJ, Scott BT, and Jones LR.Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium.J Biol Chem266: 11126–11130, 1991.

Pihakaski-Maunsbach K, Tokonabe S, Vorum H, Rivard CJ, Capasso JM, Berl T, and Maunsbach AB.The γ-subunit of Na-K-ATPase is incorporated into plasma membranes of mouse IMCD3 cells in response to hypertonicity.Am J Physiol Renal Physiol288: F650–F657, 2005.

10.1074/jbc.M010836200

10.1074/jbc.M201009200

10.1016/S0272-6386(00)70257-5

Rose AMand Valdes R.Understanding the sodium pump and its relevance to disease.Clin Chem40: 1674–1685, 1994.

10.1007/s00335-003-2282-z

10.1016/S0378-1119(01)00745-4

Segall L, Scanzano R, Kaunisto MA, Wessman M, Palotie A, Gargus JJ, and Blostein R.Kinetic alterations due to a missense mutation in the Na,K-ATPase α2subunit cause familial hemiplegic migraine type 2.J BiolChem279: 43692–43696, 2004.

10.1111/j.1469-7793.2001.t01-1-00407.x

10.1152/ajprenal.2001.280.3.F505

10.1158/1078-0432.CCR-0633-03

10.1200/JCO.2003.06.179

10.1016/S0272-6386(98)70023-X

10.1016/j.cardiores.2004.09.005

10.1006/geno.2000.6274

10.1006/bbrc.2000.3907

10.1152/ajpcell.2000.279.3.C541

10.1016/S0022-2836(02)00781-7

10.1074/jbc.272.51.32628

10.1074/jbc.274.18.12252

10.1023/A:1010619623841

10.1038/35015017

10.1093/glycob/cwg065

10.1002/ana.10674

10.1042/bj3040635

10.1152/ajprenal.1996.271.2.F322

10.1074/jbc.M405622200

10.1152/ajprenal.00241.2002

10.1016/S0169-328X(00)00213-8

10.1073/pnas.96.25.14517

10.1152/ajpheart.00698.2002

10.1074/jbc.M308610200